Search results
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 6 days agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
Factbox-Battles over CEO pay across the globe By Reuters
Investing.com· 10 hours agoMusk said late on Wednesday that shareholders were voting by wide margins to approve the pay...
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
Investor's Business Daily· 3 days agoInternational stocks, at large, are perking up in 2024. Novo Nordisk, ASML Holding, AstraZeneca, SAP...
Factbox-Battles over CEO pay across the globe
Investing.com· 11 hours agoMusk said late on Wednesday that shareholders were voting by wide margins to approve the pay package. Musk's proposed pay package, the largest in...
A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?
Medscape· 11 hours agoAdding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast...
State Drug Pricing Boards Forge Ahead With Eyes on Amgen Suit
Bloomberg Law· 3 days agoState affordability boards seeking to limit what health plans pay for prescription drugs are confident they will withstand legal challenges as Colorado battles what’s expected to be the first ...
Significant Benefit With Liver Transplantation in ACLF
Medscape· 11 hours agoLiver transplantation improves survival in patients with acute-on-chronic liver failure (ACLF),...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks· 6 days agoEli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
Most CEOs are defeating attempts to vote down their pay. Can Tesla's Elon Musk do the same?
Yahoo Finance· 3 days agoMost bosses are defeating shareholder attempts so far this year to tamp down their pay. The question...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...